FLGT Fulgent Genetics PE ratio, current and historical analysis
The current PE ratio of FLGT cannot be calculated, as the latest EPS of -$1.41 is negative. Fulgent Genetics's last PE ratio on record was 6.26 in December 2022.
FLGT PE ratio history
The mean historical PE ratio of Fulgent Genetics over the last eight years is 18.88. Looking back at the last eight years, FLGT's PE ratio peaked in the Jun 2020 quarter at 123.08, with a price of $16 and an EPS of $0.13. The Mar 2022 quarter marked the lowest point at 4.05, with a price of $62.41 and an EPS of $15.42.
Fulgent Genetics PE ratio by year
Maximum annual increase: 7.38% in 2022
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $18.47 | -$1.41 |
| 2023 | N/A | N/A | $28.91 | -$5.63 |
| 2022 | 6.26 | 7.38% | $29.78 | $4.76 |
| 2021 | 5.83 | 5.62% | $100.59 | $17.25 |
| 2020 | 5.52 | N/A | $52.1 | $9.44 |
| 2019 | N/A | N/A | $12.9 | -$0.02 |
| 2018 | N/A | N/A | $3.17 | -$0.31 |
| 2017 | N/A | N/A | $4.38 | -$0.14 |
| 2016 | N/A | N/A | $11.57 | -$1 |
| 2015 | N/A | N/A | N/A | -$0.61 |
| 2014 | N/A | N/A | N/A | N/A |
Fulgent Genetics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | N/A | N/A | $18.47 | -$1.41 |
| Sep 2024 | N/A | N/A | $21.73 | -$5.52 |
| Jun 2024 | N/A | N/A | $19.62 | -$5.48 |
| Mar 2024 | N/A | N/A | $21.7 | -$5.57 |
| Dec 2023 | N/A | N/A | $28.91 | -$5.63 |
| Sep 2023 | N/A | N/A | $26.74 | -$2.11 |
| Jun 2023 | N/A | N/A | $37.03 | -$1.61 |
| Mar 2023 | N/A | N/A | $31.22 | -$0.85 |
| Dec 2022 | 6.26 | 47.64% | $29.78 | $4.76 |
| Sep 2022 | 4.24 | 1.44% | $38.12 | $8.99 |
| Jun 2022 | 4.18 | 3.21% | $54.53 | $13.06 |
| Mar 2022 | 4.05 | -30.53% | $62.41 | $15.42 |
| Dec 2021 | 5.83 | 36.53% | $100.59 | $17.25 |
| Sep 2021 | 4.27 | -11.78% | $89.95 | $21.07 |
| Jun 2021 | 4.84 | -17.55% | $92.23 | $19.05 |
FLGT average PE ratio chart
FLGT PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| OBIO Orchestra BioMed Holdings Inc | N/A | $145.97M |
| OM Outset Medical Inc | N/A | $29.83M |
| OPK Opko Health Inc | N/A | $1.16B |
| NEO Neogenomics Inc | N/A | $1.22B |
| FLGT Fulgent Genetics Inc | N/A | $523.48M |
Frequently asked questions
What is Fulgent Genetics's PE ratio?
The current price to earnings ratio of FLGT cannot be determined, as its EPS of -$1.41 is negative.
What is the 5-year average PE ratio for Fulgent Genetics (FLGT)?
As an average over the last 5 years, FLGT stock has a PE ratio of 16.97.
What is the highest PE ratio for FLGT?
The highest quarterly PE ratio in the last eight years has been 123.08 and it was in the Jun 2020 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.